By Alex Baldwin ( November 17, 2022, 1:55 PM GMT) -- Bayer has claimed that two rival drugmakers, Sandoz and Accord, plan on releasing generic blood-thinning treatments that will infringe a key U.K. patent for its best-selling drug Xarelto, shortly after the two companies asked a London court to revoke the patent....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.